Kelly Bolton
Heads Her Own Lab
Credentials: · · · · · · · ·
History

- Present
WUSM
- 2016–2018
Medical Oncology

2009–2013
Research
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Nature Genetics · 2020 · First of 64 authors · 651 citations
Nature Medicine · 2020 · 562 citations
JAMA · 2012 · First of 78 authors · 516 citations

22 papers
- LD
10 papers
- LB
9 papers
- SC
9 papers

7 papers
- KO
7 papers

6 papers

6 papers · 1 as a resident
Grants
- 2024–2029
The Impact of Inherited and Modifiable Risk Factors on Clonal Hematopoiesis and Age-Related Disease
National Institute on Aging · R01
Contact PI · $5.9M · Washington University
- 2019–2024
Impact of Oncologic Therapy on Clonal Hematopoiesis and Subsequent Risk of Therapy-Related Leukemia
National Cancer Institute · K08
Contact PI · $1.2M · Washington University
Clinical trials
- 2022–2030
Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1
Principal investigator · Active not recruiting · Phase 2
Washington University School of Medicine
- 2024–2034
Sub-investigator · Recruiting
Washington University School of Medicine
- 2024–2027
Sub-investigator · Recruiting · Phase 1
Washington University School of Medicine
- 2016–2030
Aging, Geriatric Syndromes and Clonal Hematopoiesis
Sub-investigator · Recruiting
Washington University School of Medicine

